Dr Plus Dental Daily Care

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the prevention of dental cavities. It is intended for use in individuals at risk of developing dental caries.

Dosage and Administration

Adults and children aged 12 years and older are instructed to chew an ingot and brush with an interdental brush or continue chewing until it is fully dissolved in the mouth. Following this, they should gargle with some water and then spit it out to assist in maintaining oral hygiene. This process can be performed at any time and in any location.

For children aged 6 years to under 12 years, the use of the ingot should be supervised by an adult to ensure proper administration and safety.

The product is not recommended for use in children under 6 years of age.

Contraindications

Use is contraindicated in the event of accidental ingestion beyond the recommended amount for cleaning purposes. In such cases, immediate medical assistance or contact with a Poison Control Center is advised. No other contraindications have been identified.

Warnings and Precautions

Patients should discontinue use and consult a dentist if they experience any oral irritation or tooth sensitivity. These symptoms may indicate an adverse reaction that requires professional evaluation.

In the event of accidental ingestion of more than the recommended amount for cleaning, it is imperative to seek emergency medical assistance immediately. Contacting a Poison Control Center is also advised to ensure appropriate management of the situation.

Additionally, patients are advised to stop taking the product and contact their healthcare provider if they experience any concerning symptoms, although specific instructions for this scenario were not provided. Regular monitoring and communication with healthcare professionals are essential for safe use.

Side Effects

Patients should be advised to discontinue use and consult a dentist if they experience oral irritation or tooth sensitivity. These reactions warrant immediate attention to prevent further complications.

In clinical trials and postmarketing experiences, the occurrence of these adverse reactions has been noted, emphasizing the importance of monitoring for any signs of discomfort in the oral cavity. It is crucial for patients to be aware of these potential reactions to ensure timely intervention and management.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dr Plus Dental Daily Care (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 years to under 12 years should be supervised during use. The safety and efficacy of this medication have not been established in children under 6 years of age; therefore, its use is not recommended in this population.

Geriatric Use

There is no specific information regarding the use of Dr Plus Dental Daily Care (sodium fluoride tablet, orally disintegrating) in geriatric patients. Consequently, there are no established dosage adjustments, safety concerns, or special precautions that are specifically indicated for elderly patients.

Healthcare providers should exercise clinical judgment when prescribing this medication to geriatric patients, considering the absence of data on this population. Monitoring for any potential adverse effects or interactions is advisable, as elderly patients may have different pharmacokinetic and pharmacodynamic responses compared to younger individuals.

Pregnancy

There is no information available regarding the use of DR PLUS DENTAL DAILY CARE (sodium fluoride tablet, orally disintegrating) during pregnancy. Consequently, the safety of this medication in pregnant patients has not been established, and there are no specific dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes.

Lactation

There are no specific warnings or recommendations regarding the use of this medication in nursing mothers. Additionally, there are no specific warnings or recommendations concerning lactation. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If the substance involved is known, specific antidotes or treatments may be indicated, and healthcare professionals should refer to established guidelines for the management of overdose related to that substance.

In all cases, contacting a poison control center or a medical toxicologist for guidance is recommended to ensure appropriate management and intervention.

Nonclinical Toxicology

No relevant information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no pertinent data concerning nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if a patient accidentally swallows more than the amount intended for cleaning, they should seek medical assistance or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and preventing potential harm.

Storage and Handling

The product is supplied in its original packaging, which should be kept intact until use to ensure stability and efficacy. It is essential to store the product at room temperature, specifically within the range of 20°C to 25°C (68°F to 77°F). The product must be protected from light to maintain its integrity.

Any unused product should be discarded after the expiration date. Additionally, it is important to note that the product should not be frozen, as this may compromise its quality and effectiveness.

Additional Clinical Information

The product is administered via the dental route. Patients aged 12 years and older are instructed to chew an ingot and use an interdental brush or allow it to dissolve in the mouth, followed by gargling with water and spitting it out to maintain oral hygiene. For children aged 6 to under 12 years, supervision during use is required, while the product is not recommended for children under 6 years of age.

Patients should be advised to discontinue use and consult a dentist if they experience oral irritation or tooth sensitivity. It is essential to keep the product out of reach of children, and in the event of accidental ingestion beyond the recommended amount, medical assistance or contact with a Poison Control Center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Dr Plus Dental Daily Care, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)